LACTULOSE Side Effects

6979663-2 | Abdominal Distension, Groin Pain
on Sep 10, 2010 Male patient from UNITED STATES , 64 years of age, weighting 220.0 lb, was diagnosed with constipation (What is constipation?) and was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, groin pain. Lactulose dosage: 2 Tbsp 2x Daily Mouth. Patient was hospitalized.

6779928-3 | Delirium, Electrolyte Imbalance, Pleural Effusion, Rhabdomyolysis
Patient was taking Lactulose (View Usage). Patient had the following side effects: delirium, electrolyte imbalance, pleural effusion, rhabdomyolysis on Jun 14, 2010 from Additional patient health information: Female patient , 87 years of age, was diagnosed with constipation prophylaxis, electrolyte imbalance and. Lactulose dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), CALCIUM GLUCONATE (10 Ml) (View Calcium Gluconate Review and Calcium Gluconate Label ), SORBITOL (View Sorbitol Review and Sorbitol Label ), VALSARTAN/HYDROCHLOROTHIAZIDE (View Valsartan/hydrochlorothiazide Review and Valsartan/hydrochlorothiazide Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), POTASSIUM CHLORIDE (60 Meq) (View Potassium Chloride Review and Potassium Chloride Label ), SODIUM CHLORIDE (40 Meq) (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6725515-2 | Chest Pain, Electrocardiogram St Segment Depression
Adverse event was reported on May 03, 2010 by a Male patient taking Lactulose (View Usage) (Dosage: Daily Dose: 60 Millilitre(s)) was diagnosed with constipation (What is constipation?), hypertension, asthenia, colorectal cancer (What is colorectal cancer?) and. Location: UNITED KINGDOM , weighting 211.6 lb, After Lactulose was administered, patient had the following side effects: chest pain (What is chest pain?), electrocardiogram st segment depression. During the same period patient was treated with DOCUSATE (Daily Dose: 200 Milligram(s)) (View Docusate Review and Docusate Label ), DEXAMETHASONE (Daily Dose: 4 Milligram(s)) (View Dexamethasone Review and Dexamethasone Label ), DOXAZOSIN MESYLATE (Daily Dose: 8 Milligram(s)) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ATENOLOL (Daily Dose: 100 Milligram(s)) (View Atenolol Review and Atenolol Label ), CALCIUM FOLINATE (Daily Dose: 450mg 1 In 2 Weeks) (View Calcium Folinate Review and Calcium Folinate Label ), FLUOROURACIL (Daily Dose: 925 Mg 1 In 2 Wks) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6676083-5 | Asthenia, Bradycardia, Chest Pain, Constipation, Electrocardiogram St Segment Depression
on Apr 02, 2010 Male patient from UNITED KINGDOM , weighting 211.6 lb, was diagnosed with constipation (What is constipation?), hypertension, asthenia, colorectal cancer (What is colorectal cancer?) and was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bradycardia, chest pain (What is chest pain?), constipation (What is constipation?), electrocardiogram st segment depression. Lactulose dosage: Daily Dose: 60 Millilitre(s). During the same period patient was treated with DOCUSATE (Daily Dose: 200 Milligram(s)) (View Docusate Review and Docusate Label ), DEXAMETHASONE (Daily Dose: 4 Milligram(s)) (View Dexamethasone Review and Dexamethasone Label ), DOXAZOSIN (Daily Dose: 8 Milligram(s)) (View Doxazosin Review and Doxazosin Label ), ATENOLOL (Daily Dose: 100 Milligram(s)) (View Atenolol Review and Atenolol Label ), CALCIUM FOLINATE (Daily Dose: 450mg 1 In 2 Weeks) (View Calcium Folinate Review and Calcium Folinate Label ), FLUOROURACIL (Daily Dose: 925 Mg 1 In 2 Wks) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.


6631337-3 | Hyponatraemia
on Mar 11, 2010 Male patient from UNITED STATES , 64 years of age, weighting 173.1 lb, was diagnosed with hyperlipidaemia, hyponatraemia and was treated with Lactulose (View Usage). Patient had the following side effects: hyponatraemia. Lactulose dosage: 30 Ml Bid Po. Patient was hospitalized.

6585573-5 | Agitation, Akathisia, Anaesthetic Complication, Caesarean Section, Coma Scale Abnormal, Confusional State, Cough, Disorientation
Patient was taking Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: agitation, akathisia, anaesthetic complication, caesarean section, coma scale abnormal, confusional state, cough, disorientation on Feb 08, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 39 years of age, weighting 114.6 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Lactulose dosage: . During the same period patient was treated with OLANZAPINE (20 Mg) (View Olanzapine Review and Olanzapine Label ), CLONAZEPAM (NGX) (0.5 Mg, Qd) (View Clonazepam (ngx) Review and Clonazepam (ngx) Label ), FOLIC ACID (NGX) (500 Mcg Daily) (View Folic Acid (ngx) Review and Folic Acid (ngx) Label ), METOCLOPRAMIDE HYDROCHLORIDE (10 Mg, Unk) (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ), LITHIUM (1.7 G Per Day) (View Lithium Review and Lithium Label ), RANITIDINE (50 Mg, Unk) (View Ranitidine Review and Ranitidine Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ), THIOPENTAL SODIUM (250 Mg, Unk) (View Thiopental Sodium Review and Thiopental Sodium Label ). Patient was hospitalized.

6433661-6 | Blood Creatinine Increased, Blood Urea Increased, Renal Impairment, Weight Decreased
Adverse event was reported on Nov 06, 2009 by a Male patient taking Lactulose (View Usage) (Dosage: 15 Ml Bid Po) was diagnosed with hepatitis alcoholic, ascites and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, renal impairment, weight decreased. During the same period patient was treated with FUROSEMIDE (40 Mg Am Po) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6383227-1 | Condition Aggravated, Encephalopathy, Gastrointestinal Haemorrhage, Incorrect Product Storage, Infection, Liquid Product Physical Issue, Product Measured Potency Issue, Product Substitution Issue
on Sep 14, 2009 Female patient from UNITED STATES , 62 years of age, weighting 145.0 lb, was diagnosed with hepatic encephalopathy and was treated with Lactulose (View Usage). Patient had the following side effects: condition aggravated, encephalopathy, gastrointestinal haemorrhage, incorrect product storage, infection (What is infection?), liquid product physical issue, product measured potency issue, product substitution issue. Lactulose dosage: 30ml 4 Times Daily 047. During the same period patient was treated with URSODIOL 250 MG (View Ursodiol 250 Mg Review and Ursodiol 250 Mg Label ), XIFAXAN (ANTIBIOTIC) 200MG (View Xifaxan (antibiotic) 200mg Review and Xifaxan (antibiotic) 200mg Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), HUMULIN R (View Humulin R Review and Humulin R Label ).

6311706-1 | Body Temperature Increased, Constipation, Fluid Retention, Headache, Lymphadenopathy, Pain, Shock, Stress, Weight Increased
on Aug 13, 2009 Female patient from UNITED STATES , 41 years of age, weighting 130.0 lb, was diagnosed with septic shock and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: body temperature increased, constipation (What is constipation?), fluid retention, headache (What is headache?), lymphadenopathy, pain (What is pain?), shock, stress (What is stress?), weight increased. Lactulose dosage: 3 Times A Day, Every Day I Use New Supplier Bay Co. - Lot's Better.

6284456-8 | Product Quality Issue
Patient was taking Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue on Jul 16, 2009 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 150.0 lb, was diagnosed with constipation (What is constipation?) and. Lactulose dosage: 3 Tbsp In Evening 047. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), BENICAR (View Benicar Review and Benicar Label ).

6139901-5 | Condition Aggravated, Hypersensitivity, Swelling, Viral Infection
Adverse event was reported on Mar 18, 2009 by a Female patient taking Lactulose (View Usage) (Dosage: 30 Ml;bid; Po) was diagnosed with constipation (What is constipation?) and. Location: CANADA , 56 years of age, Patient had the following side effects: condition aggravated, hypersensitivity, swelling, viral infection (What is viral infection?). During the same period patient was treated with KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), HYOSCINE BUTYLBROMIDE (HYOSCINE SUTYLBROMIDE) (View Hyoscine Butylbromide (hyoscine Sutylbromide) Review and Hyoscine Butylbromide (hyoscine Sutylbromide) Label ). Patient was hospitalized.

5963732-X | Anger, Emotional Disorder, Faeces Discoloured, Food Craving, Lethargy, Mood Swings
on Nov 21, 2008 Male patient from UNITED STATES , child 7 years of age, weighting 50.00 lb, was diagnosed with constipation (What is constipation?), faecaloma and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: anger, emotional disorder, faeces discoloured, food craving, lethargy, mood swings. Lactulose dosage: 10 Cc Twice A Day Po.

5874936-9 | Agitation, Akathisia, Blood Creatinine Increased, Confusional State, Delayed Recovery From Anaesthesia, Disorientation, Glasgow Coma Scale Abnormal, Hydronephrosis
on Sep 01, 2008 Female patient from UNITED KINGDOM , 39 years of age, weighting 114.6 lb, was diagnosed with poor quality sleep, bipolar disorder (What is bipolar disorder?), agitation and was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, akathisia, blood creatinine increased, confusional state, delayed recovery from anaesthesia, disorientation, glasgow coma scale abnormal, hydronephrosis. Lactulose dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), LITHIUM (View Lithium Review and Lithium Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), THIOPENTONE (View Thiopentone Review and Thiopentone Label ). Patient was hospitalized.

5834758-1 | Agitation, Anaemia Of Pregnancy, Anaesthetic Complication, Caesarean Section, Confusional State, Continuous Haemodiafiltration, Cough, Delayed Recovery From Anaesthesia, Disorientation
Patient was taking Lactulose (View Usage). Patient had the following side effects: agitation, anaemia of pregnancy, anaesthetic complication, caesarean section, confusional state, continuous haemodiafiltration, cough, delayed recovery from anaesthesia, disorientation on Jul 24, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 39 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Lactulose dosage: . During the same period patient was treated with OLANZAPINE (20 Mg) (View Olanzapine Review and Olanzapine Label ), CLONAZEPAM (0.5 Mg, Qd) (View Clonazepam Review and Clonazepam Label ), FOLIC ACID (500 Mcg Daily) (View Folic Acid Review and Folic Acid Label ), METOCLOPRAMIDE (10 Mg) (View Metoclopramide Review and Metoclopramide Label ), LITHIUM CARBONATE (1.7 G Per Day) (View Lithium Carbonate Review and Lithium Carbonate Label ), RANITIDINE (50 Mg, Intravenous) (View Ranitidine Review and Ranitidine Label ), SODIUM CITRATE (Oral) (View Sodium Citrate Review and Sodium Citrate Label ), THIOPENTAL SODIUM (250 Mg) (View Thiopental Sodium Review and Thiopental Sodium Label ). Patient was hospitalized.

5826812-5 | Vomiting
Adverse event was reported on Jul 28, 2008 by a Male patient taking Lactulose (View Usage) (Dosage: 30 Ml Every 2 Hours Other) was diagnosed with constipation (What is constipation?) and. Location: UNITED STATES , 19 years of age, weighting 110.0 lb, After Lactulose was administered, patient had the following side effects: vomiting.

5763431-3 | Constipation
on Jun 04, 2008 Male patient from UNITED STATES , weighting 133.0 lb, was diagnosed with constipation (What is constipation?) and was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?). Lactulose dosage: 1 Tbsp Bid Po. During the same period patient was treated with ANUSOL (View Anusol Review and Anusol Label ), LORATADINE (View Loratadine Review and Loratadine Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5745822-X | Agitation, Anaemia Of Pregnancy, Anaesthetic Complication, Blood Sodium Decreased, Blood Urea Increased, Caesarean Section, Confusional State, Cough, Disorientation
on May 07, 2008 Female patient from UNITED STATES , 39 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Lactulose (View Usage). Patient had the following side effects: agitation, anaemia of pregnancy, anaesthetic complication, blood sodium decreased, blood urea increased, caesarean section, confusional state, cough, disorientation. Lactulose dosage: . During the same period patient was treated with OLANZAPINE (20 Mg) (View Olanzapine Review and Olanzapine Label ), CLONAZEPAM (0.5 Mg, Qd) (View Clonazepam Review and Clonazepam Label ), FOLIC ACID (500 Mcg Daily) (View Folic Acid Review and Folic Acid Label ), METOCLOPRAMIDE (10 Mg) (View Metoclopramide Review and Metoclopramide Label ), LITHIUM CARBONATE (1.7 G Per Day) (View Lithium Carbonate Review and Lithium Carbonate Label ), RANITIDINE (50 Mg, Intravenous) (View Ranitidine Review and Ranitidine Label ), SODIUM CITRATE (Oral) (View Sodium Citrate Review and Sodium Citrate Label ), THIOPENTAL SODIUM (250 Mg) (View Thiopental Sodium Review and Thiopental Sodium Label ). Patient was hospitalized.

5729129-2 | Nausea
Patient was taking Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: nausea (What is nausea?) on May 05, 2008 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with constipation (What is constipation?) and. Lactulose dosage: 3ml Qd.

5703542-1 | Abdominal Pain, Colonic Atony, Constipation, Faecaloma, Megacolon, Pneumatosis Intestinalis, Pneumoperitoneum
Adverse event was reported on Mar 31, 2008 by a Male patient taking Lactulose (View Usage) (Dosage: 30 Ml, Tid, Oral; 45 Ml, Qid,; 60 Ml, Qid, Oral; Daily Enemas Were Given, Rectal) was diagnosed with constipation (What is constipation?) and. Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), colonic atony, constipation (What is constipation?), faecaloma, megacolon, pneumatosis intestinalis, pneumoperitoneum. During the same period patient was treated with DULCOLAX (Each Evening,) (View Dulcolax Review and Dulcolax Label ), NEOMYCIN (2 G, Qd,) (View Neomycin Review and Neomycin Label ). Patient was hospitalized.

5692252-5 | Jaundice
on Mar 19, 2008 Male patient from UNITED KINGDOM , 86 years of age, was treated with Lactulose (View Usage). Patient had the following side effects: jaundice (What is jaundice?). Lactulose dosage: 10 Ml, Bid, Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CETOSTEARYL ALCOHOL(CETOSTEARYL ALCOHOL) (View Cetostearyl Alcohol(cetostearyl Alcohol) Review and Cetostearyl Alcohol(cetostearyl Alcohol) Label ). Patient was hospitalized.

5691901-5 | Jaundice
on Mar 19, 2008 Male patient from UNITED KINGDOM , 86 years of age, was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: jaundice (What is jaundice?). Lactulose dosage: 10 Ml, Bid, Oral. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CETOSTEARYL ALCOHOL(CETOSTEARYL ALCOHOL) (View Cetostearyl Alcohol(cetostearyl Alcohol) Review and Cetostearyl Alcohol(cetostearyl Alcohol) Label ). Patient was hospitalized.

5671312-9 | Jaundice
Patient was taking Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?) on Feb 27, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 86 years of age, . Lactulose dosage: 10 Ml, Bid, Oral. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5663849-3 | Jaundice
Adverse event was reported on Feb 27, 2008 by a Male patient taking Lactulose (View Usage) (Dosage: 10 Ml, Bid, Oral) . Location: UNITED KINGDOM , 86 years of age, Patient had the following side effects: jaundice (What is jaundice?). During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5628675-X | Ammonia Increased, Amnesia
on Feb 15, 2008 Female patient from UNITED STATES , 43 years of age, weighting 185.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: ammonia increased, amnesia. Lactulose dosage: 30 Ml Q Dau Po. Patient was hospitalized.

5536356-6 | Anorectal Disorder, Gastrointestinal Haemorrhage, Post Procedural Complication, Rectal Ulcer
on Nov 20, 2007 Female patient from UNITED STATES , 76 years of age, was diagnosed with hepatic encephalopathy and was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: anorectal disorder, gastrointestinal haemorrhage, post procedural complication, rectal ulcer. Lactulose dosage: ;1x;rtl. Patient was hospitalized.

5536354-2 | Lower Gastrointestinal Haemorrhage, Rectal Fissure, Thrombosis
Patient was taking Lactulose (View Usage). Patient had the following side effects: lower gastrointestinal haemorrhage, rectal fissure, thrombosis on Nov 20, 2007 from UNITED STATES Additional patient health information: Male patient , 51 years of age, was diagnosed with hepatic encephalopathy, hepatorenal syndrome and. Lactulose dosage: ;1x;rtl. Patient was hospitalized.

5536351-7 | Lower Gastrointestinal Haemorrhage, Procedural Complication, Rectal Fissure
Adverse event was reported on Nov 20, 2007 by a Male patient taking Lactulose (View Usage) (Dosage: ;1x;rtl) was diagnosed with hepatic encephalopathy and. Location: UNITED STATES , 52 years of age, After Lactulose was administered, patient had the following side effects: lower gastrointestinal haemorrhage, procedural complication, rectal fissure.

5522862-7 | Dental Caries
on Nov 01, 2007 Female patient from UNITED KINGDOM , child 10 years of age, was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: dental caries. Lactulose dosage: (10 Ml).

5515288-3 | Gastrointestinal Haemorrhage
on Nov 08, 2007 Male patient from , 51 years of age, was treated with Lactulose (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Lactulose dosage: . Patient was hospitalized.

5515287-1 | Gastrointestinal Haemorrhage
Patient was taking Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: gastrointestinal haemorrhage on Nov 08, 2007 from Additional patient health information: Male patient , 52 years of age, . Lactulose dosage: .

5515284-6 | Gastrointestinal Haemorrhage
Adverse event was reported on Nov 08, 2007 by a Female patient taking Lactulose (View Usage) (Dosage: ) . Location: , 76 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage.

5472289-1 | Abdominal Distension, Abdominal Pain, Asterixis, Chronic Hepatic Failure, Colonic Atony, Confusional State, Constipation, Encephalopathy, Faecaloma
on Sep 17, 2007 Male patient from UNITED STATES , 57 years of age, was diagnosed with constipation (What is constipation?) and was treated with Lactulose (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), asterixis, chronic hepatic failure, colonic atony, confusional state, constipation (What is constipation?), encephalopathy, faecaloma. Lactulose dosage: 30 Ml, Tid, Oral, 45 Ml, Qid, 60 Ml, Qid, Oral, Daily Enemas Were Given, Rectal. During the same period patient was treated with DULCOLAX (Each Evening) (View Dulcolax Review and Dulcolax Label ), NEOMYCIN (2 G, Qd) (View Neomycin Review and Neomycin Label ). Patient was hospitalized.

5469967-7 | Hepatic Cirrhosis, Hepatic Failure, Portal Hypertension
on Sep 14, 2007 Female patient from UNITED STATES , 56 years of age, weighting 135.0 lb, was diagnosed with back pain (What is back pain?) and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: hepatic cirrhosis, hepatic failure, portal hypertension. Lactulose dosage: . During the same period patient was treated with MIRTAZAPINE (15 Mg, Daily (1/d)) (View Mirtazapine Review and Mirtazapine Label ), GABAPENTIN (300 Mg, 2/d) (View Gabapentin Review and Gabapentin Label ), LORAZEPAM (0.5 Mg, 4/d) (View Lorazepam Review and Lorazepam Label ), METHOCARBAMOL (750 Mg, 2/d) (View Methocarbamol Review and Methocarbamol Label ), PROMETHAZINE (25 Mg, Daily (1/d)) (View Promethazine Review and Promethazine Label ), TRAMADOL HCL (50 Mg, 3/d) (View Tramadol Hcl Review and Tramadol Hcl Label ), HYDROCODONE BITARTRATE + ACETAMINOPHEN (1 D/f, 4/d) (View Hydrocodone Bitartrate + Acetaminophen Review and Hydrocodone Bitartrate + Acetaminophen Label ). Patient was hospitalized.

5409386-2 | Bradycardia, Dehydration, Hypotension, Renal Failure Acute
Patient was taking Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, dehydration, hypotension, renal failure acute on Aug 08, 2007 from UNITED STATES Additional patient health information: Male patient , 80 years of age, was diagnosed with liver disorder and. Lactulose dosage: 20gm Every Day Po. During the same period patient was treated with METOPROLOL SUCCINATE (50mg Every Day Po) (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

5324506-6 | Anaemia, Blood Potassium Decreased, Clubbing, Cough, Melanosis, Renal Failure Chronic, Urine Analysis Abnormal, Weight Decreased
Adverse event was reported on Apr 26, 2007 by a Female patient taking Lactulose (View Usage) (Dosage: Qd) . Location: UNITED KINGDOM , 62 years of age, Patient had the following side effects: anaemia, blood potassium decreased, clubbing, cough, melanosis, renal failure chronic, urine analysis abnormal, weight decreased. During the same period patient was treated with SENNA (View Senna Review and Senna Label ). Patient was hospitalized.

5323960-3 | Amnesia, Confusional State, Diarrhoea, Disturbance In Attention, Sleep Disorder
on May 09, 2007 Male patient from UNITED STATES , 55 years of age, weighting 186.0 lb, was diagnosed with blood bilirubin increased, encephalopathy and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: amnesia, confusional state, diarrhoea, disturbance in attention, sleep disorder (What is sleep disorder?). Lactulose dosage: 30 Cc Qday Po.

5310970-5 | Anaemia, Blood Potassium Decreased, Clubbing, Cough, Diarrhoea, Incorrect Dose Administered, Melanosis Coli
on Apr 11, 2007 Female patient from UNITED KINGDOM , 62 years of age, was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood potassium decreased, clubbing, cough, diarrhoea, incorrect dose administered, melanosis coli. Lactulose dosage: . During the same period patient was treated with SENNA ALEXANDRINA (View Senna Alexandrina Review and Senna Alexandrina Label ). Patient was hospitalized.

5269153-X | Anaemia, Clubbing, Cough, Weight Decreased
Patient was taking Lactulose (View Usage). Patient had the following side effects: anaemia, clubbing, cough, weight decreased on Mar 12, 2007 from Additional patient health information: Female patient , 62 years of age, was diagnosed with laxative abuse and. Lactulose dosage: . During the same period patient was treated with SENNA (View Senna Review and Senna Label ). Patient was hospitalized.

5212996-9 | Lower Respiratory Tract Infection, Pneumonia, Toxic Epidermal Necrolysis
Adverse event was reported on Jan 02, 2007 by a Male patient taking Lactulose (View Usage) (Dosage: 10 Ml,) . Location: UNITED KINGDOM , 54 years of age, After Lactulose was administered, patient had the following side effects: lower respiratory tract infection, pneumonia (What is pneumonia?), toxic epidermal necrolysis. During the same period patient was treated with ACTRAPID HUMAN (INSULIN HUMAN) (Intravenous) (View Actrapid Human (insulin Human) Review and Actrapid Human (insulin Human) Label ), ALFENTANIL (View Alfentanil Review and Alfentanil Label ), AMOXICILLIN (1g, Tid, Intravenous) (View Amoxicillin Review and Amoxicillin Label ), AQUASEPT (TRICLOSAN) (View Aquasept (triclosan) Review and Aquasept (triclosan) Label ), BACTROBAN (MUPIROCIN) (View Bactroban (mupirocin) Review and Bactroban (mupirocin) Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), CALCIUM GLUCONATE (10 Ml, Intravenous) (View Calcium Gluconate Review and Calcium Gluconate Label ), CEFTRIAXONE (2g, Unk; Intravenous) (View Ceftriaxone Review and Ceftriaxone Label ).

5165353-8 | Gout
on Jul 03, 2006 Female patient from UNITED KINGDOM , 86 years of age, weighting 120.2 lb, was diagnosed with constipation (What is constipation?), depression (What is depression?), hypertension, cardiovascular disorder, hypothyroidism, breast cancer (What is breast cancer?) and was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: gout (What is gout?). Lactulose dosage: 15 Ml, Tid. During the same period patient was treated with TRIPTAFEN (1 Df Mane; 2 Df Nocte) (View Triptafen Review and Triptafen Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), SIMVASTATIN (20mg Nocte) (View Simvastatin Review and Simvastatin Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FEMARA (2.5 Mg, Qd) (View Femara Review and Femara Label ).

5160880-1 | Duodenal Ulcer, Haematemesis, Melaena
on Nov 10, 2006 Female patient from UNITED KINGDOM , 31 years of age, weighting 136.7 lb, was diagnosed with hepatitis (What is hepatitis?), pain (What is pain?) and was treated with Lactulose (View Usage). Patient had the following side effects: duodenal ulcer, haematemesis, melaena. Lactulose dosage: 10 Ml, Bid, Oral. During the same period patient was treated with PREDNISOLONE (40 Mg, Qd, Oral) (View Prednisolone Review and Prednisolone Label ), IBUPROFEN (Tid, Oral) (View Ibuprofen Review and Ibuprofen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), THIAMINE (View Thiamine Review and Thiamine Label ), BENZODIAZEPINES NO INGREDIENTS/SUBSTANCES) (View Benzodiazepines No Ingredients/substances) Review and Benzodiazepines No Ingredients/substances) Label ). Patient was hospitalized.

5153644-6 | Duodenal Ulcer, Encephalopathy, Haematemesis, Melaena
Patient was taking Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: duodenal ulcer, encephalopathy, haematemesis, melaena on Oct 30, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 31 years of age, weighting 136.7 lb, was diagnosed with hepatitis (What is hepatitis?), pain (What is pain?) and. Lactulose dosage: 10 Ml, Bid, Oral. During the same period patient was treated with PREDNISOLONE (40 Mg, Qd, Oral) (View Prednisolone Review and Prednisolone Label ), IBUPROFEN (3 Df, Qd, Oral) (View Ibuprofen Review and Ibuprofen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), THIAMINE (THIAMINE) (View Thiamine (thiamine) Review and Thiamine (thiamine) Label ), BENZODIAZEPINES (View Benzodiazepines Review and Benzodiazepines Label ). Patient was hospitalized.

5150525-9 | Abdominal Pain, Back Pain, Bone Density Decreased, Cholelithiasis, Condition Aggravated, Haemorrhagic Diathesis, Spinal Fracture
Adverse event was reported on Sep 17, 2006 by a Male patient taking Lactulose (View Usage) (Dosage: ) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: UNITED STATES , 40 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), bone density decreased, cholelithiasis, condition aggravated, haemorrhagic diathesis, spinal fracture. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ENBREL (View Enbrel Review and Enbrel Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PROTONIX (View Protonix Review and Protonix Label ), MIACALCIN (Unk, Unk) (View Miacalcin Review and Miacalcin Label ). Patient was hospitalized.

5148766-X | Gamma-glutamyltransferase Increased
on Aug 11, 2006 Female patient from GERMANY , 85 years of age, weighting 164.2 lb, was treated with Lactulose (View Usage). Patient had the following side effects: gamma-glutamyltransferase increased. Lactulose dosage: 1 Df, Bid. During the same period patient was treated with PANTOZOL (20 Mg, Qd) (View Pantozol Review and Pantozol Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), METOHEXAL (0.5 Df, Bid) (View Metohexal Review and Metohexal Label ), TRAMADOLOR (150 Mg, Qd) (View Tramadolor Review and Tramadolor Label ), FERRLECIT (1 Df, Qw2) (View Ferrlecit Review and Ferrlecit Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), ASCORBIC ACID (0.2 Df, Qw3) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

5129961-2 | Food Intolerance, Hyperemesis Gravidarum
on Oct 02, 2006 Female patient from UNITED KINGDOM , 36 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: food intolerance, hyperemesis gravidarum. Lactulose dosage: . During the same period patient was treated with ONDANSETRON (10 Mg (5 Mg, 2 In 1 D) Oral) (View Ondansetron Review and Ondansetron Label ).

5078535-0 | Abdominal Pain
Patient was taking Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?) on Jul 24, 2006 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with constipation (What is constipation?) and. Lactulose dosage: 2 Tblsp, 2x Day, Oral. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NORVASC (View Norvasc Review and Norvasc Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ).

5063063-9 | Incorrect Dose Administered
Adverse event was reported on Jul 07, 2006 by a Female patient taking Lactulose (View Usage) (Dosage: 2 Tblsp, 2x Day, Oral) was diagnosed with constipation (What is constipation?) and. Location: UNITED STATES , 79 years of age, weighting 123.0 lb, Patient had the following side effects: incorrect dose administered. During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), ACTONEL (View Actonel Review and Actonel Label ), INDERAL (View Inderal Review and Inderal Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), CYTOTEC (View Cytotec Review and Cytotec Label ).

5061380-X | Hypotension
on Jul 19, 2006 Male patient from UNITED STATES , 80 years of age, was diagnosed with constipation (What is constipation?), hypertension and was treated with Lactulose (View Usage). After Lactulose was administered, patient had the following side effects: hypotension. Lactulose dosage: 30 Ml Qd. During the same period patient was treated with FUROSEMIDE (20 Mg Bid) (View Furosemide Review and Furosemide Label ), FELODIPINE (5mg Qam) (View Felodipine Review and Felodipine Label ), VARDENAFIL (View Vardenafil Review and Vardenafil Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), COLCHICINE (View Colchicine Review and Colchicine Label ). Patient was hospitalized.

5047151-9 | Non-hodgkin's Lymphoma
on Jun 16, 2006 Female patient from UNITED KINGDOM , 78 years of age, was treated with Lactulose (View Usage). Patient experienced the following unwanted or unexpected effects: non-hodgkin's lymphoma. Lactulose dosage: Oral. During the same period patient was treated with LANSOPRAZOLE (15 Milligram, Oral) (View Lansoprazole Review and Lansoprazole Label ), QUININE SULFATE (300 Milligram, Oral) (View Quinine Sulfate Review and Quinine Sulfate Label ), SALBUTAMOL (4 Milligram, Respiratory) (View Salbutamol Review and Salbutamol Label ), AQUEOUS CREAM (View Aqueous Cream Review and Aqueous Cream Label ), DEXAMETHASONE TAB (Oral) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ACETAMINOPHEN (Oral) (View Acetaminophen Review and Acetaminophen Label ), SENNA (Oral) (View Senna Review and Senna Label ), SERETIDE (FLUTICASONE PROPINATE AND SALMETEROL XINAFOATE) (Respiratory) (View Seretide (fluticasone Propinate And Salmeterol Xinafoate) Review and Seretide (fluticasone Propinate And Salmeterol Xinafoate) Label ).

4963371-3 | Dehydration, Diarrhoea, Vomiting
Patient was taking Lactulose (View Usage). Patient had the following side effects: dehydration, diarrhoea, vomiting on Apr 04, 2006 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 167.0 lb, . Lactulose dosage: 30 Mg Po Bid. Patient was hospitalized.